{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:42:12Z","timestamp":1789778532324,"version":"4.0.1"},"reference-count":137,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.gofs.2021.03.020","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T20:52:22Z","timestamp":1616273542000},"page":"373-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Alternatives non hormonales de prise en charge des bouff\u00e9es vasomotrices post-m\u00e9nopausiques. RPC Les femmes m\u00e9nopaus\u00e9es du CNGOF et du GEMVi"],"prefix":"10.1016","volume":"49","author":[{"given":"B.","family":"Raccah-Tebeka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Boutet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Plu-Bureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gofs.2021.03.020_bib0690","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamainternmed.2014.8063","article-title":"Study of Women's Health Across the Nation. Duration of menopausal vasomotor symptoms over the menopause transition","volume":"175","author":"Avis","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.gofs.2021.03.020_bib0695","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12905-015-0217-y","article-title":"Prevalence of menopausal symptoms among mid-life women: findings from electronic medical records","volume":"15","author":"Sussman","year":"2015","journal-title":"BMC Womens Health"},{"issue":"Suppl. 12B","key":"10.1016\/j.gofs.2021.03.020_bib0700","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2005.09.031","article-title":"Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives","volume":"118","author":"Woods","year":"2005","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.020_bib0705","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ogc.2011.05.006","article-title":"Vasomotor symptoms and menopause: findings from the Study of Women's Health across the Nation","volume":"38","author":"Thurston","year":"2011","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.020_bib0710","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.gme.0000229574.67376.ba","article-title":"Modeling women's health during the menopausal transition: a longitudinal analysis","volume":"14","author":"Dennerstein","year":"2007","journal-title":"Menopause"},{"issue":"11","key":"10.1016\/j.gofs.2021.03.020_bib0715","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1097\/GME.0000000000001241","article-title":"The 2017 hormone therapy position statement of The North American Menopause Society","volume":"25","year":"2018","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.020_bib0720","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.yfrne.2013.07.003","article-title":"Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes","volume":"34","author":"Rance","year":"2013","journal-title":"Front Neuroendocrinol"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.020_bib0725","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.gyobfe.2012.02.015","article-title":"Management of hot flushes for breast cancer survivors","volume":"40","author":"Boutet","year":"2012","journal-title":"Gynecol Obstet Fertil"},{"issue":"10081","key":"10.1016\/j.gofs.2021.03.020_bib0730","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(17)30823-1","article-title":"Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"389","author":"Prague","year":"2017","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.gofs.2021.03.020_bib0735","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1200\/JCO.2001.19.23.4280","article-title":"Methodologic lessons learned from hot flash studies","volume":"19","author":"Sloan","year":"2001","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.gofs.2021.03.020_bib0740","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1634\/theoncologist.11-6-641","article-title":"Symptoms and treatment in cancer therapy-induced early menopause","volume":"11","author":"Boekhout","year":"2006","journal-title":"Oncologist"},{"issue":"9247","key":"10.1016\/j.gofs.2021.03.020_bib0745","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.020_bib0750","first-page":"CD002978","article-title":"Oral oestrogen and combined oestrogen\/progestogen therapy versus placebo for hot flushes","author":"Maclennan","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib0755","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/PSY.0000000000000143","article-title":"Placebo improvement in pharmacologic treatment of menopausal hot flashes: time course, duration, and predictors","volume":"77","author":"Freeman","year":"2015","journal-title":"Psychosom Med"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.020_bib0760","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1016\/S1470-2045(12)70197-3","article-title":"Placebo effect in hot flush research","volume":"13","author":"Mahon","year":"2012","journal-title":"Lancet Oncol"},{"issue":"21","key":"10.1016\/j.gofs.2021.03.020_bib0765","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.289.21.2827","article-title":"Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial","volume":"289","author":"Stearns","year":"2003","journal-title":"JAMA"},{"issue":"28","key":"10.1016\/j.gofs.2021.03.020_bib0770","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1200\/JCO.2005.10.081","article-title":"Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial [published correction appears in J Clin Oncol 2005 Nov 20;23(33):8549]","volume":"23","author":"Stearns","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2007.10.007","article-title":"Paroxetine versus placebo for women in midlife after hormone therapy discontinuation","volume":"121","author":"Soares","year":"2008","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.gofs.2021.03.020_bib0780","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/GME.0b013e3182a66aa7","article-title":"Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials","volume":"20","author":"Simon","year":"2013","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.020_bib0785","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ygyno.2016.10.006","article-title":"Role of paroxetine in the management of hot flashes in gynecological cancer survivors: results of the first randomized single-center controlled trial","volume":"143","author":"Capriglione","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.gofs.2021.03.020_bib0790","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/1471-0528.13951","article-title":"Effect and safety of paroxetine for vasomotor symptoms: systematic review and meta-analysis","volume":"123","author":"Wei","year":"2016","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.020_bib0795","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00042192-200512010-00006","article-title":"Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study","volume":"12","author":"Suvanto-Luukkonen","year":"2005","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib0800","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.gme.0000243571.55699.4a","article-title":"Efficacy of citalopram on climacteric symptoms","volume":"14","author":"Kalay","year":"2007","journal-title":"Menopause"},{"issue":"20","key":"10.1016\/j.gofs.2021.03.020_bib0805","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1200\/JCO.2009.26.6379","article-title":"Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9","volume":"28","author":"Barton","year":"2010","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.gofs.2021.03.020_bib0810","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/gme.0b013e31820ccae9","article-title":"Escitalopram treatment of menopausal hot flashes","volume":"18","author":"Freedman","year":"2011","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.020_bib0815","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.2010.2016","article-title":"Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial","volume":"305","author":"Freeman","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.gofs.2021.03.020_bib0820","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.2002.20.6.1578","article-title":"Phase III evaluation of fluoxetine for treatment of hot flashes","volume":"20","author":"Loprinzi","year":"2002","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib0825","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1075-122X.2006.00218.x","article-title":"Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen","volume":"12","author":"Kimmick","year":"2006","journal-title":"Breast J"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.020_bib0830","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.gme.0000196595.82452.ca","article-title":"Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population","volume":"13","author":"Gordon","year":"2006","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.020_bib0835","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/01.AOG.0000258278.73505.fa","article-title":"Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial","volume":"109","author":"Grady","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib0840","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10549-009-0425-y","article-title":"The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer","volume":"118","author":"Wu","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.gofs.2021.03.020_bib0845","doi-asserted-by":"crossref","first-page":"c693","DOI":"10.1136\/bmj.c693","article-title":"Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study","volume":"340","author":"Kelly","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.020_bib0850","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnci\/dji005","article-title":"CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment","volume":"97","author":"Jin","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gofs.2021.03.020_bib0855","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40064-015-0808-y","article-title":"A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients","volume":"4","author":"Drewe","year":"2015","journal-title":"Springerplus"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.020_bib0860","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.maturitas.2010.08.005","article-title":"Managing menopausal symptoms and depression in tamoxifen users: implications of drug and medicinal interactions","volume":"67","author":"Desmarais","year":"2010","journal-title":"Maturitas"},{"issue":"10","key":"10.1016\/j.gofs.2021.03.020_bib0865","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1176\/appi.ajp.2008.08040482","article-title":"Drug interactions and pharmacogenomics in the treatment of breast cancer and depression","volume":"165","author":"Henry","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.020_bib0870","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.AOG.0000147840.06947.46","article-title":"Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial","volume":"105","author":"Evans","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"9247","key":"10.1016\/j.gofs.2021.03.020_bib0875","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.020_bib0880","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1634\/theoncologist.12-1-124","article-title":"Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer","volume":"12","author":"Carpenter","year":"2007","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.020_bib0885","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000297371.89129.b3","article-title":"Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial","volume":"111","author":"Speroff","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.09.877","article-title":"A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause","volume":"200","author":"Archer","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2021.03.020_bib0895","article-title":"Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety","volume":"200","author":"Archer","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.020_bib0900","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/gme.0b013e31826421a8","article-title":"Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial","volume":"20","author":"Pinkerton","year":"2013","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.020_bib0905","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/gme.0b013e318274699f","article-title":"Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms: a 1-year randomized controlled trial","volume":"20","author":"Pinkerton","year":"2013","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib0910","first-page":"337","article-title":"Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial","volume":"101","author":"Guttuso","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"9488","key":"10.1016\/j.gofs.2021.03.020_bib0915","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(05)67215-7","article-title":"Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial","volume":"366","author":"Pandya","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.020_bib0920","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.AOG.0000222383.43913.ed","article-title":"Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial","volume":"108","author":"Reddy","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib0925","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/gme.0b013e3180dca175","article-title":"Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial","volume":"15","author":"Butt","year":"2008","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.gofs.2021.03.020_bib0930","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/GME.0b013e3182a7c073","article-title":"Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause","volume":"21","author":"Pinkerton","year":"2014","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.020_bib0935","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1200\/JCO.2009.24.5647","article-title":"Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1","volume":"28","author":"Loprinzi","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5905","key":"10.1016\/j.gofs.2021.03.020_bib0940","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/bmj.1.5905.409","article-title":"Menopausal flushing: double-blind trial of a non-hormonal medication","volume":"1","author":"Clayden","year":"1974","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.020_bib0945","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JCO.1994.12.1.155","article-title":"Transdermal clonidine for ameliorating tamoxifen-induced hot flashes","volume":"12","author":"Goldberg","year":"1994","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2021.03.020_bib0950","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/0003-4819-132-10-200005160-00004","article-title":"Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study","volume":"132","author":"Pandya","year":"2000","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.gofs.2021.03.020_bib0955","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/GME.0000000000000773","article-title":"Extended-release oxybutynin therapy for vasomotor symptoms in women: a randomized clinical trial","volume":"23","author":"Simon","year":"2016","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.020_bib0960","doi-asserted-by":"crossref","first-page":"pkz088","DOI":"10.1093\/jncics\/pkz088","article-title":"Oxybutynin vs. placebo for hot flashes in women with or without breast cancer: a randomized, double-blind clinical trial (ACCRU SC-1603)","volume":"4","author":"Leon-Ferre","year":"2019","journal-title":"JNCI Cancer Spectr"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib0965","first-page":"CD004845","article-title":"Homeopathic medicines for adverse effects of cancer treatments","author":"Kassab","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.020_bib0970","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/acm.2005.11.13","article-title":"A pilot, randomized, double-blinded, placebo-controlled trial of individualized homeopathy for symptoms of estrogen withdrawal in breast cancer survivors","volume":"11","author":"Thompson","year":"2005","journal-title":"J Altern Complement Med"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.020_bib0975","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/acm.2005.11.21","article-title":"Homeopathy for menopausal symptoms in breast cancer survivors: a preliminary randomized controlled trial","volume":"11","author":"Jacobs","year":"2005","journal-title":"J Altern Complement Med"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.020_bib0980","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/11640240-000000000-00000","article-title":"Efficacy of a non-hormonal treatment, BRN-01, on menopausal hot flashes: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"12","author":"Colau","year":"2012","journal-title":"Drugs R D"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.020_bib0985","first-page":"1879","article-title":"Does a homeopathic medicine reduce hot flushes induced by adjuvant endocrine therapy in localized breast cancer patients\u00a0? A multicenter randomized placebo-controlled phase III trial","volume":"27","author":"Heudel","year":"2019","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib0990","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/JCO.1998.16.2.495","article-title":"Prospective evaluation of vitamin E for hot flashes in breast cancer survivors","volume":"16","author":"Barton","year":"1998","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.020_bib0995","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000106491","article-title":"The effect of vitamin E on hot flashes in menopausal women","volume":"64","author":"Ziaei","year":"2007","journal-title":"Gynecol Obstet Invest"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.020_bib1000","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/13697130902736921","article-title":"Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E","volume":"12","author":"Biglia","year":"2009","journal-title":"Climacteric"},{"key":"10.1016\/j.gofs.2021.03.020_bib1005","first-page":"2385","article-title":"ABUFENE 400 mg et bouff\u00e9es de chaleur. \u00c9tude en double aveugle versus placebo","volume":"5","author":"Roueche","year":"1991","journal-title":"Rev Prat Med Gen"},{"key":"10.1016\/j.gofs.2021.03.020_bib1010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejogrb.2018.07.008","article-title":"Effect of omega-3 supplements on vasomotor symptoms in menopausal women: a systematic review and meta-analysis","volume":"228","author":"Mohammady","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4 Suppl.","key":"10.1016\/j.gofs.2021.03.020_bib1015","doi-asserted-by":"crossref","first-page":"1362S","DOI":"10.1093\/jn\/131.4.1362S","article-title":"Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements","volume":"131","author":"Setchell","year":"2001","journal-title":"J Nutr"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib1020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/13697137.2014.966241","article-title":"Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review","volume":"18","author":"Chen","year":"2015","journal-title":"Climacteric"},{"issue":"12","key":"10.1016\/j.gofs.2021.03.020_bib1025","first-page":"CD001395","article-title":"Phytoestrogens for menopausal vasomotor symptoms","author":"Lethaby","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"23","key":"10.1016\/j.gofs.2021.03.020_bib1030","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1001\/jama.2016.8012","article-title":"Use of plant-based therapies and menopausal symptoms: a systematic review and meta-analysis","volume":"315","author":"Franco","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.gofs.2021.03.020_bib1035","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/bcp.12533","article-title":"quantitative efficacity of soy isoflavones on menopausal hot flahes","volume":"79","author":"Li","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.020_bib1040","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3109\/13697137.2014.999660","article-title":"Effectiveness of red clover in alleviating menopausal symptoms: a 12-week randomized, controlled trial","volume":"18","author":"Shakeri","year":"2015","journal-title":"Climacteric"},{"issue":"9","key":"10.1016\/j.gofs.2021.03.020_bib1045","first-page":"CD007244","article-title":"Black cohosh (Cimicifuga spp.) for menopausal symptoms","volume":"2012","author":"Leach","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gofs.2021.03.020_bib1050","first-page":"CD009023","article-title":"Chinese herbal medicine for menopausal symptoms","volume":"3","author":"Zhu","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gofs.2021.03.020_bib1055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.maturitas.2019.03.023","article-title":"Effect of oral phytoestrogens on endometrial thickness and breast density of perimenopausal and postmenopausal women: a systematic review and meta-analysis","volume":"124","author":"Mareti","year":"2019","journal-title":"Maturitas"},{"issue":"7","key":"10.1016\/j.gofs.2021.03.020_bib1060","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/gme.0b013e31824017bc","article-title":"The pollen extract Femal\u00a0\u2013\u00a0a nonestrogenic alternative to hormone therapy in women with menopausal symptoms","volume":"19","author":"Hellstr\u00f6m","year":"2012","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib1065","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/13697130500117987","article-title":"Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study","volume":"8","author":"Winther","year":"2005","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.020_bib1070","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/09513590.2018.1538347","article-title":"Prospective observational study to evaluate the efficacy and safety of the pollen extract S\u00e9r\u00e9lys\u00ae in the management of women with menopausal symptoms","volume":"35","author":"Fait","year":"2019","journal-title":"Gynecol Endocrinol"},{"issue":"11","key":"10.1016\/j.gofs.2021.03.020_bib1075","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/GME.0000000000000535","article-title":"Does purified Swedish pollen extract, a nonhormonal treatment for vasomotor symptoms, inhibit the CYP2D6 enzyme system\u00a0?","volume":"22","author":"Goldstein","year":"2015","journal-title":"Menopause"},{"issue":"6927","key":"10.1016\/j.gofs.2021.03.020_bib1080","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/bmj.308.6927.501","article-title":"Effect of oral gamolenic acid from evening primrose oil on menopausal flushing","volume":"308","author":"Chenoy","year":"1994","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.020_bib1085","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00404-013-2852-6","article-title":"The effect of oral evening primrose oil on menopausal hot flashes: a randomized clinical trial","volume":"288","author":"Farzaneh","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"38","key":"10.1016\/j.gofs.2021.03.020_bib1090","doi-asserted-by":"crossref","first-page":"e4914","DOI":"10.1097\/MD.0000000000004914","article-title":"Ginseng for managing menopausal woman's health: a systematic review of double-blind, randomized, placebo-controlled trials","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.gofs.2021.03.020_bib1095","first-page":"CD007410","article-title":"Acupuncture for menopausal hot flushes","volume":"2013","author":"Dodin","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib1100","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/GME.0000000000000260","article-title":"Effects of acupuncture on menopause-related symptoms and quality of life in women in natural menopause: a meta-analysis of randomized controlled trials","volume":"22","author":"Chiu","year":"2015","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.020_bib1105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/acm.2016.0408","article-title":"Management of menopause symptoms with acupuncture: an umbrella systematic review and meta-analysis","volume":"24","author":"Befus","year":"2018","journal-title":"J Altern Complement Med"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.020_bib1110","doi-asserted-by":"crossref","first-page":"e023637","DOI":"10.1136\/bmjopen-2018-023637","article-title":"Efficacy of a standardised acupuncture approach for women with bothersome menopausal symptoms: a pragmatic randomised study in primary care (the ACOM study)","volume":"9","author":"Lund","year":"2019","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.gofs.2021.03.020_bib1115","first-page":"4895","article-title":"Acupuncture for treating hot flashes in breast cancer patients: an updated meta-analysis","volume":"24","author":"Salehi","year":"2016","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib1120","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/13697137.2019.1664460","article-title":"The maintenance effect of acupuncture on breast cancer-related menopause symptoms: a systematic review","volume":"23","author":"Chien","year":"2020","journal-title":"Climacteric"},{"issue":"31","key":"10.1016\/j.gofs.2021.03.020_bib1125","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1200\/JCO.2008.16.6389","article-title":"Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors","volume":"26","author":"Elkins","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.020_bib1130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/gme.0b013e31826ce3ed","article-title":"Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial","volume":"20","author":"Elkins","year":"2013","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.gofs.2021.03.020_bib1135","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/GME.0000000000000837","article-title":"Efficacy of a biobehavioral intervention for hot flashes: a randomized controlled pilot study","volume":"24","author":"Barton","year":"2017","journal-title":"Menopause"},{"issue":"11","key":"10.1016\/j.gofs.2021.03.020_bib1140","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/GME.0000000000000546","article-title":"Nonhormonal management of menopaue-associated vasomotor symptoms: 2015 position statment of The North American Menopause Society","volume":"22","year":"2015","journal-title":"Menopause"},{"issue":"9","key":"10.1016\/j.gofs.2021.03.020_bib1145","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/da.22762","article-title":"Yoga for anxiety: a systematic review and meta-analysis of randomized controlled trials","volume":"35","author":"Cramer","year":"2018","journal-title":"Depress Anxiety"},{"issue":"11","key":"10.1016\/j.gofs.2021.03.020_bib1150","first-page":"CD006108","article-title":"Exercise for vasomotor menopausal symptoms","author":"Daley","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.020_bib1155","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/1471-0528.13193","article-title":"The effectiveness of exercise as treatment for vasomotor menopausal symptoms: randomised controlled trial","volume":"122","author":"Daley","year":"2015","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.020_bib1160","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/1471-0528.15153","article-title":"Mindfulness, cognitive behavioural and behaviour-based therapy for natural and treatment-induced menopausal symptoms: a systematic review and meta-analysis","volume":"126","author":"van Driel","year":"2019","journal-title":"BJOG"},{"issue":"7","key":"10.1016\/j.gofs.2021.03.020_bib1165","first-page":"CD008582","article-title":"Relaxation for perimenopausal and postmenopausal symptoms","author":"Saensak","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.020_bib1170","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/gme.0b013e318272ce80","article-title":"Effects of applied relaxation on vasomotor symptoms in postmenopausal women: a randomized controlled trial","volume":"20","author":"Lindh-\u00c5strand","year":"2013","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.020_bib1175","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/AOG.0000000000000821","article-title":"Device-guided slow-paced respiration for menopausal hot flushes: a randomized controlled trial","volume":"125","author":"Huang","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib1180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/GME.0b013e31826934b6","article-title":"Paced breathing compared with usual breathing for hot flashes","volume":"20","author":"Sood","year":"2013","journal-title":"Menopause"},{"issue":"9","key":"10.1016\/j.gofs.2021.03.020_bib1185","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcma.2016.01.020","article-title":"Effect of lavender aromatherapy on menopause hot flushing: a crossover randomized clinical trial","volume":"79","author":"Kazemzadeh","year":"2016","journal-title":"J Chin Med Assoc"},{"issue":"9","key":"10.1016\/j.gofs.2021.03.020_bib1190","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/gme.0b013e318248ea16","article-title":"Effect of aromatherapy massage on menopausal symptoms: a randomized placebo-controlled clinical trial","volume":"19","author":"Darsareh","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.gofs.2021.03.020_bib1195","first-page":"29","article-title":"Comparison of the efficacy of massage therapy and aromatherapy massage with geranium on depression in postmenopausal women: a clinical trial","volume":"15","author":"Lotfipur-Rafsanjani","year":"2015","journal-title":"Zahedan J Res Med Sci"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.020_bib1200","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ctim.2013.03.007","article-title":"The effect of aromatherapy massage on the psychological symptoms of postmenopausal Iranian women","volume":"21","author":"Taavoni","year":"2013","journal-title":"Complement Ther Med"},{"issue":"9","key":"10.1016\/j.gofs.2021.03.020_bib1205","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1471-0528.2002.01504.x","article-title":"Randomised controlled trial of reflexology for menopausal symptoms","volume":"109","author":"Williamson","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.gofs.2021.03.020_bib1210","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ctcp.2016.05.011","article-title":"The effect of foot reflexology applied to women aged between 40 and 60 on vasomotor complaints and quality of life","volume":"24","author":"Gozuyesil","year":"2016","journal-title":"Complement Ther Clin Pract"},{"issue":"17","key":"10.1016\/j.gofs.2021.03.020_bib1215","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","article-title":"Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis","volume":"295","author":"Nelson","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.020_bib1220","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11606-013-2535-9","article-title":"SSRIs for hot flashes: a systematic review and meta-analysis of randomized trials","volume":"29","author":"Shams","year":"2014","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.gofs.2021.03.020_bib1225","series-title":"Menopausal symptoms: comparative effectiveness of therapies","author":"Grant","year":"2015"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib1230","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10549-015-3465-5","article-title":"Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis","volume":"152","author":"Ramaswami","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.020_bib1235","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4314\/ejhs.v24i3.4","article-title":"Is desvenlafaxine effective and safe in the treatment of menopausal vasomotor symptoms\u00a0? A meta-analysis and meta-regression of randomized double-blind controlled studies","volume":"24","author":"Berhan","year":"2014","journal-title":"Ethiop J Health Sci"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib1240","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clinthera.2009.02.006","article-title":"Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis","volume":"31","author":"Toulis","year":"2009","journal-title":"Clin Ther"},{"issue":"10","key":"10.1016\/j.gofs.2021.03.020_bib1245","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/1471-0528.14619","article-title":"Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause","volume":"124","author":"Sarri","year":"2017","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.020_bib1250","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/gme.0b013e3181d672f6","article-title":"The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care","volume":"17","author":"Hickey","year":"2010","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.020_bib1255","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humupd\/dmn064","article-title":"Breast cancer in young women and its impact on reproductive function","volume":"15","author":"Hickey","year":"2009","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.020_bib1260","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/annonc\/mdl478","article-title":"Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients\u00a0\u2013\u00a0a double-blind, randomized study","volume":"18","author":"Loibl","year":"2007","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.020_bib1265","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10549-008-0138-7","article-title":"Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized crossover study","volume":"115","author":"Buijs","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.020_bib1270","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JCO.1994.12.1.155","article-title":"Transdermal clonidine for ameliorating tamoxifen-induced hot flashes [published correction appears in J Clin Oncol 1996 Aug;14(8):2411]","volume":"12","author":"Goldberg","year":"1994","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2021.03.020_bib1275","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.6004\/jnccn.2010.0086","article-title":"Nonhormonal management of hot flashes for women on risk reduction therapy","volume":"8","author":"Sideras","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.020_bib1280","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10549-016-3765-4","article-title":"Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions","volume":"156","author":"Johns","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.020_bib1285","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/gme.0b013e31818c91ca","article-title":"Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis","volume":"16","author":"Bardia","year":"2009","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.020_bib1290","first-page":"1461","article-title":"Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations","volume":"21","author":"L\u2019Esp\u00e9rance","year":"2013","journal-title":"Support Care Cancer"},{"issue":"10","key":"10.1016\/j.gofs.2021.03.020_bib1295","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00432-013-1491-4","article-title":"The efficacy of nonestrogenic therapy to hot flashes in cancer patients under hormone manipulation therapy: a systematic review and meta-analysis","volume":"139","author":"Yamaguchi","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib1300","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10549-016-4002-x","article-title":"Adverse effects of non-hormonal pharmacological interventions in breast cancer survivors, suffering from hot flashes: a systematic review and meta-analysis","volume":"160","author":"Hervik","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.gofs.2021.03.020_bib1305","first-page":"CD004923","article-title":"Non-hormonal interventions for hot flushes in women with a history of breast cancer","author":"Rada","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib1310","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clinthera.2007.02.006","article-title":"Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review","volume":"29","author":"Bordeleau","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.gofs.2021.03.020_bib1315","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ctrv.2016.11.012","article-title":"Management of hot flashes in women with breast cancer receiving ovarian function suppression","volume":"52","author":"Leon-Ferre","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.020_bib1320","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12282-015-0655-2","article-title":"The pharmacological and hormonal therapy of hot flushes in breast cancer survivors","volume":"23","author":"Wi\u015bniewska","year":"2016","journal-title":"Breast Cancer"},{"issue":"6","key":"10.1016\/j.gofs.2021.03.020_bib1325","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","article-title":"American Cancer Society\/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline","volume":"34","author":"Runowicz","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gofs.2021.03.020_bib1330","unstructured":"NCCN Guidelines: Breast Cancer: NCCN Evidence blocks version version 01.2019 26 Apr 2019 nccn.org."},{"key":"10.1016\/j.gofs.2021.03.020_bib1335","unstructured":"NICE breast cancer https:\/\/www.nice.org.uk\/guidance\/conditions-and-diseases\/cancer\/breast-cancer\/."},{"key":"10.1016\/j.gofs.2021.03.020_bib1340","unstructured":"Comit\u00e9 de l\u2019\u00e9volution des pratiques en oncologie (CEPO) du minist\u00e8re de la Sant\u00e9 et des Services sociaux du Qu\u00e9bec. http:\/\/www.inesss.qc.ca."},{"issue":"5S","key":"10.1016\/j.gofs.2021.03.020_bib1345","doi-asserted-by":"crossref","first-page":"744","DOI":"10.6004\/jnccn.2017.0090","article-title":"Life after treatment: quality-of-life concerns in patients treated for cancer","volume":"15","author":"Goldman","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"issue":"11","key":"10.1016\/j.gofs.2021.03.020_bib1350","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/GME.0000000000000546","article-title":"Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society","volume":"22","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.gofs.2021.03.020_bib1355","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2147\/IJWH.S50804","article-title":"Critical appraisal of paroxetine for the treatment of vasomotor symptoms","volume":"7","author":"Carroll","year":"2015","journal-title":"Int J Womens Health"},{"issue":"17","key":"10.1016\/j.gofs.2021.03.020_bib1360","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1200\/JCO.2008.19.6253","article-title":"Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis","volume":"27","author":"Loprinzi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gofs.2021.03.020_bib1365","unstructured":"Le National Comprehensive Cancer Network (NCCN) [JNCCN 2017], https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast_basic.pdf."},{"issue":"7","key":"10.1016\/j.gofs.2021.03.020_bib0685","doi-asserted-by":"crossref","first-page":"869","DOI":"10.4158\/EP171828.PS","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinologogy position statement on menopause\u00a0\u2013\u00a02017 update","volume":"23","author":"Cobin","year":"2017","journal-title":"Endocr Pract"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718921000702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718921000702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:41:51Z","timestamp":1762854111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718921000702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":137,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2468718921000702"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2021.03.020","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternatives non hormonales de prise en charge des bouff\u00e9es vasomotrices post-m\u00e9nopausiques. RPC Les femmes m\u00e9nopaus\u00e9es du CNGOF et du GEMVi","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2021.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}